Quick Answer
Janux Therapeutics, Inc. reported Shares Outstanding of 60.38 million shares for fiscal year 2025.
Janux Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 60.38M | +2.2% |
| 2024 | 59.06M | +27.7% |
| 2023 | 46.25M | +11.1% |
| 2022 | 41.62M | +0.9% |
| 2021 | 41.24M | +3840.7% |
| 2020 | 1.05M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 60.12M | +14.9% | +1.4% |
| June 30, 2025 | 59.30M | +13.7% | +0.2% |
| March 31, 2025 | 59.17M | +14.1% | +0.2% |
| December 31, 2024 | 59.06M | +27.7% | +12.9% |
| September 30, 2024 | 52.34M | +13.4% | +0.3% |
| June 30, 2024 | 52.16M | +24.6% | +0.6% |
| March 31, 2024 | 51.84M | +24.0% | +12.1% |
| December 31, 2023 | 46.25M | +11.1% | +0.2% |
- Janux Therapeutics, Inc. showed an increase of +2.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Janux Therapeutics, Inc.’s shares outstanding has grown by 5669.6% (from 1.05 million shares to 60.38 million shares).
- The most recent figure is from Janux Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: